6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Back
Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand
Journal article   Peer reviewed

Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand

Andrew Anglemyer, Andrea McNeill, Kara DuBray, Gerard J. B. Sonder and Tony Walls
Clinical infectious diseases, Vol.74(10), pp.1859-1861
30/05/2022
DOI: https://doi.org/10.1093/cid/ciab766
Handle:
https://hdl.handle.net/10523/41678

Abstract

Immunology Infectious Diseases Life Sciences & Biomedicine Microbiology Science & Technology
New Zealand (NZ) is one of few countries to shift from PCV13 to PCV10. The number of serotype 19A cases in young children and the proportions of isolates that are penicillin-resistant have been steadily increasing since. It is time for NZ to reconsider its choice of pneumococcal vaccine.

Metrics

2 Record Views
13 Times Cited - Web of Science

Details

Logo image